Defibrotide in sinusoidal obstruction syndrome: mounting evidence in pediatric patients (Commentary on Qureshi et al., page 831).
Del Toro
Gustavo
G
Jack Martin Division of Pediatric Hematology/Oncology, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1208, New York, New York 10029, USA. gustavo.deltoro@mssm.edu
D002648:Child; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006504:Hepatic Veno-Occlusive Disease / Q000517:prevention & control*; D006801:Humans; D011089:Polydeoxyribonucleotides / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D011089:Polydeoxyribonucleotides; C036901:defibrotide